Transcription factor and epigenetic regulation of hypoxic gene expression
Transcription factor and epigenetic regulation of hypoxic gene expression
批准号:
7524057
负责人:
ANDREW L KUNG
金额:
$34.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-07-01 至 2013-04-30
关键词:
AcetylationAnemiaBindingBinding SitesBiochemicalBioinformaticsCellsChromatinChromatin StructureDNADNA BindingDataData SetDevelopmentDevelopmental ProcessDiseaseEmerging TechnologiesEpigenetic ProcessErythrocytesErythropoietinFamilyFunctional disorderGene ExpressionGene Expression ProfilingGene TargetingGenesGenomeGenomicsHeart DiseasesHistonesHomeostasisHuman GenomeHypoxiaInflammationIschemiaKnowledgeLocalizedMalignant NeoplasmsMapsMediatingMediator of activation proteinMetabolicMethodologyMethylationModificationMolecular ProfilingNeoplasm MetastasisOxygenOxygen measurement, partial pressure, arterialPatternPhysiological ProcessesPhysiologyPlayProductionRegulationResourcesResponse ElementsRoleSignal TransductionSpecificityStrokeStructureThinkingTissuesTrans-ActivatorsTransactivationTranscription CoactivatorTumor PromotionWound Healingangiogenesisbasechromatin immunoprecipitationchromatin proteinhypoxia inducible factor 1new technologyprogramsresearch clinical testingresponsetranscription factortumortumor growth
中文摘要
描述(由申请人提供):所有电池都需要氧气才能正常工作。对氧水平降低(缺氧)的协调转录反应通过短期和长期适应机制维持体内平衡。两种结构相似的转录因子,缺氧诱导因子1和2(HIF-1和HIF-2),被认为是缺氧诱导的基因表达的主要介质。HIF在正常发育、控制红细胞生成、伤口愈合和对缺血性疾病的反应中起关键作用。不幸的是,它们在促进肿瘤生长方面也起着重要作用。越来越多的证据表明HIF-1和HIF-2在功能上并不相同,尽管这些差异的机制基础尚不清楚。使用一种新兴的技术,ChIP芯片,我们已经全面确定了所有区域的基因组中的结合HIF-1,并已整合这些数据与基因表达谱建立HIF-1结合和基因反式激活之间的功能关系。在本提案的第一个具体目标中,我们将使用相同的方法来鉴定HIF-2结合位点和基因反式激活。我们将确定HIF-1和HIF-2的特异性缺失对基因表达的影响,并将寻找决定HIF-1和HIF-2在DNA结合和基因反式激活方面差异的机制。整合这些不同的数据集,我们将建立一个全面的观点,HIF-1和HIF-2是如何相似的,以及它们作为转录激活因子的主要功能是如何不同的。基因表达也受到染色质局部结构的极大影响。在第二个特定目标中,我们将使用ChIP芯片来绘制特定组蛋白修饰的基线和缺氧诱导的变化,包括乙酰化和甲基化,这些修饰调节染色质结构。当与HIF-1结合,HIF-2结合和基因表达谱整合时,这些全球性和基因特异性研究将建立对缺氧反应中调节基因表达的反式作用和表观遗传机制网络的理解。特别是,我们希望确定表观遗传学如何调节HIF与DNA的结合,表观遗传学如何影响HIF的基因表达,以及缺氧/HIF如何改变表观遗传学。这一知识是至关重要的战略,以增加或减少缺氧基因表达的进展进入临床测试。
英文摘要
DESCRIPTION (provided by applicant): All cells require oxygen for proper functioning. A coordinated transcriptional response to decreased oxygen levels (hypoxia) maintains homeostasis through short-term and long-term adaptive mechanisms. Two structurally similar transcription factors, Hypoxia-Inducible Factor 1 and 2 (HIF-1 and HIF-2), are thought to be the primary mediators of hypoxia-induced gene expression. The HIFs play critical roles in normal development, control of red blood cell production; wound healing, and response to ischemic diseases. Unfortunately, they also play important roles in promoting tumor growth. Mounting evidence suggests that HIF-1 and HIF-2 are not identical in function, although the mechanistic basis for these differences is not known. Using an emerging technology, ChIP-chip, we have comprehensively identified all regions of the genome that are bound by HIF-1, and have integrated these data with gene expression profiling to establish a functional relationship between HIF-1 binding and gene transactivation. In the first Specific Aim of this proposal, we will use the same approaches to identify HIF-2 binding sites and gene transactivation. We will determine the effects of specific loss of HIF-1 and HIF-2 on gene expression, and will search for mechanisms that dictate differences between HIF-1 and HIF-2 in their DNA binding and gene transactivation. Integrating these diverse datasets, we will establish a comprehensive view of how HIF-1 and HIF-2 are similar and how they differ in their primary function as transcriptional activators. Gene expression is also greatly influenced by the localized structure of chromatin. In the second Specific Aim, we will use ChIP-chip to map the baseline and hypoxia-induced changes in specific histone modifications, including acetylation and methylation, which regulate chromatin structure. When integrated with HIF-1 binding, HIF-2 binding, and gene expression profiles, these global and gene-specific studies will establish an understanding of the network of trans-acting and epigenetic mechanisms regulating gene expression in response to hypoxia. In particular, we wish to define how epigenetics modulate HIF binding to DNA, how epigenetics impact gene expression by HIF, and in turn how hypoxia/HIF alters epigenetics. This knowledge is critical as strategies to increase or decrease hypoxic gene expression progress into clinical testing.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Leveraging in vivo models to identify epigenetic vulnerabilities in leukemia
-
批准号:8878386
-
项目类别:
-
资助金额:$17.4万
-
财政年份:2015
-
负责人:ANDREW L KUNG
-
依托单位:
Functionizing the epigenome in Ewing sarcoma
-
批准号:8281286
-
项目类别:
-
资助金额:$22.84万
-
财政年份:2012
-
负责人:ANDREW L KUNG
-
依托单位:
Targeting the ETS Transcription Factor Rearrangement EWS/FLI in Ewing's Sarcoma
-
批准号:8460824
-
项目类别:
-
资助金额:$4.24万
-
财政年份:2012
-
负责人:ANDREW L KUNG
-
依托单位:
Functionizing the epigenome in Ewing sarcoma
-
批准号:8658180
-
项目类别:
-
资助金额:$16.36万
-
财政年份:2012
-
负责人:ANDREW L KUNG
-
依托单位:
Targeting the ETS Transcription Factor Rearrangement EWS/FLI in Ewing's Sarcoma
-
批准号:8327461
-
项目类别:
-
资助金额:$4.38万
-
财政年份:2012
-
负责人:ANDREW L KUNG
-
依托单位:
A novel probe for imaging apoptosis
-
批准号:7896941
-
项目类别:
-
资助金额:$21.5万
-
财政年份:2010
-
负责人:ANDREW L KUNG
-
依托单位:
A novel probe for imaging apoptosis
-
批准号:8069318
-
项目类别:
-
资助金额:$25.4万
-
财政年份:2010
-
负责人:ANDREW L KUNG
-
依托单位:
Transcription factor and epigenetic regulation of hypoxic gene expression
-
批准号:8637299
-
项目类别:
-
资助金额:$18.87万
-
财政年份:2008
-
负责人:ANDREW L KUNG
-
依托单位:
Transcription factor and epigenetic regulation of hypoxic gene expression
-
批准号:8251221
-
项目类别:
-
资助金额:$13.35万
-
财政年份:2008
-
负责人:ANDREW L KUNG
-
依托单位:
Transcription factor and epigenetic regulation of hypoxic gene expression
-
批准号:8063984
-
项目类别:
-
资助金额:$33.52万
-
财政年份:2008
-
负责人:ANDREW L KUNG
-
依托单位:
Transcription factor and epigenetic regulation of hypoxic gene expression
-
批准号:7637887
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2008
-
负责人:ANDREW L KUNG
-
依托单位:
Transcription factor and epigenetic regulation of hypoxic gene expression
-
批准号:7808056
-
项目类别:
-
资助金额:$33.86万
-
财政年份:2008
-
负责人:ANDREW L KUNG
-
依托单位:
Hypoxia inducible transcription in antitumor strategies
-
批准号:6917092
-
项目类别:
-
资助金额:$15.74万
-
财政年份:2001
-
负责人:ANDREW L KUNG
-
依托单位:
Hypoxia inducible transcription in antitumor strategies
-
批准号:6608143
-
项目类别:
-
资助金额:$15.74万
-
财政年份:2001
-
负责人:ANDREW L KUNG
-
依托单位:
Hypoxia inducible transcription in antitumor strategies
-
批准号:6369049
-
项目类别:
-
资助金额:$13.58万
-
财政年份:2001
-
负责人:ANDREW L KUNG
-
依托单位:
Hypoxia inducible transcription in antitumor strategies
-
批准号:6766920
-
项目类别:
-
资助金额:$15.74万
-
财政年份:2001
-
负责人:ANDREW L KUNG
-
依托单位:
Hypoxia inducible transcription in antitumor strategies
-
批准号:6515210
-
项目类别:
-
资助金额:$15.74万
-
财政年份:2001
-
负责人:ANDREW L KUNG
-
依托单位:
国内基金
海外基金
基于构建骨骼类器官模型探究Fanconi anemia信号通路调控电刺激诱导神经化成骨过程的机制研究
-
批准号:82302715
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:熊泽康
-
依托单位:
FANCM蛋白在传统Fanconi anemia通路以外对保护基因组稳定性的功能
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2021
-
负责人:陈英伟
-
依托单位:
范可尼贫血(Fanconi Anemia)基因FANCM在复制后修复中的作用及FA癌症抑制通路的机制研究
-
批准号:31200592
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:孙伟力
-
依托单位: